Selskabets formål er forskning, udvikling og kommercialisering af lægemidler.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | - | -43 mio. | 46.1 mio. | 26.1 mio. | 8 | |
CVR: 38231170
Compared to 994 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Companies in the same industry and area
CVR 45436497
CVR 37018899
CVR 44478587
CVR 43506242
CVR 40766383
Camilla Petrycer Hansen left the board
Kuang He left the board
Jean Marcel André Combalbert joined as ADM. DIR.
Torsten Meldgaard Madsen left as ADM. DIR.
registered with 20% ownership
registered with 10% ownership
companydata.dk